Clinically, COVID‐19 causes lymphocytopaenia (up to 82% of patients), elevations of inflammatory markers including C‐reactive protein (CRP), D‐dimer, interleukins and tumour necrosis factor‐alpha (TNF‐α).8, 9. Here, TNF is linked to COVID-19.